Ipsen presents strong full-year 2022 results and guidance for 2023
- 09 February 2023 - 1 mins read
Paris (France), 9 February 2023
Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents today its financial results for the year and the fourth quarter of 2022.
